Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment. Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA491894
下载链接
链接失效反馈官方服务：
资源简介：
The miRNA expression profiling between Control and Luteolin in 22Rv1 Overall design: 22Rv1 cells were treated 25 μM luteolin for 48 hours.
创建时间：
2018-09-19
